3-(Tributylstannyl)allyl Alcohols
451
Compound 2s. 1H NMR (CDCl3): 7.74–7.80 m , 2 H (Ar); 7.41–7.53 m , 3 H (Ar); 6.32 bs, 1 H
(NH); 6.05 t, 1 H, J = 6.5, 3J(Sn -H,cis) = 65 (=CH); 4.26–4.35 m , 4 H, 3J(Sn -H) = 47 (CH2OH,
CH2NH); 2.78 t, 1 H, J = 5.7 (OH); 1.20–1.60 m , 12 H (Sn CH2CH2CH2CH3); 0.82–1.05 m , 15 H
(Sn CH2CH2CH2CH3). 13C NMR, APT (CDCl3): 168.05, 144.73, 134.93, 59.17, 42.70, 29.83,
28.08, 10.46 (CH2, C); 142.87, 132.31, 129.31, 127.53, 14.33 (CH3, CH). IR (CHCl3): 3 613,
3 453, 3 010, 2 959, 2 927, 2 874, 2 853, 1 656, 1 518, 1 485, 1 462, 1 340, 1 074, 1 002. For
C
23H39NO2Sn (480.3) calculated: 57.52% C, 8.19% H, 2.92% N; foun d: 57.56% C, 7.90% H,
2.76% N.
(E)-4-(3-Fluoroben zam ido)-3-(tributylstan n yl)but-2-en -1-ol (2u )
an d (E)-4-(3-Fluoroben zam ido)-2-(tributylstan n yl)but-2-en -1-ol (22)
Th ese stan n an es were prepared as described for com poun ds 2s an d 2l. From a on e m m ol re-
action 0.224 g (45%) of 22 (less polar) an d 0.193 g (38%) of 2u (m ore polar) was obtain ed.
Compound 22. 1H NMR (CDCl3): 7.45–7.53 m , 2 H (Ar); 7.36–7.45 m , 1 H (Ar); 7.15–7.24 m ,
1 H (Ar); 6.26 bs, 1 H (NH); 5.61 t, 1 H, J = 6.6, 3J(Sn -H,cis) = 66 (=CH); 4.47 d, 2 H, J = 5.3,
3J(Sn -H) = 38 (CH2OH); 4.11 t, 2 H, J = 6.1 (CH2NH); 2.20 t, 1 H, J = 5.2 (OH); 1.25–1.62 m ,
12 H (Sn CH2CH2CH2CH3); 0.82–1.05 m , 15 H (Sn CH2CH2CH2CH3). 13C NMR, APT (CDCl3):
166.89, 164.70, 162.23, 151.27, 137.47, 63.90, 39.29, 29.84, 28.08, 10.72 (CH2, C); 134.81,
131.02, 123.19, 119.25, 115.10, 14.42 (CH3, CH). IR (CHCl3): 3 617, 3 451, 3 015, 2 958, 2 927,
2 872, 1 659, 1 500, 1 520, 1 482, 1 292, 1 271, 1 023. For C23H38FNO2Sn (498.3) calculated:
55.47% C, 7.69% H, 2.81% N; foun d: 55.46% C, 7.52% H, 2.99% N.
Compound 2n . 1H NMR (CDCl3): 7.45–7.53 m , 2 H (Ar); 7.35–7.45 m , 1 H (Ar); 7.15–7.24 m ,
1 H (Ar); 6.34 bs, 1 H (NH); 6.05 t, 1 H, J = 6.6, 3J(Sn -H,cis) = 66 (=CH); 4.24–4.34 m , 4 H,
3J(Sn -H)
= 48 (CH2OH, CH2NH); 2.62 t, 1 H, J = 5.8 (OH); 1.20–1.65 m , 12 H
(Sn CH2CH2CH2CH3); 0.80–1.05 m , 15 H (Sn CH2CH2CH2CH3). 13C NMR, APT (CDCl3):
166.64, 164.75, 162.29, 144.71, 137.28, 59.18, 42.75, 29.82, 28.07, 10.46 (CH2, C);
142.97, 131.00, 122.96, 119.31, 115.09, 14.32 (CH3, CH). IR (CHCl3): 3 447, 3 363, 3 010,
2 959, 2 927, 2 873, 2 854, 1 658, 1 588, 1 518, 1 482, 1 468, 1 292, 1 271, 1 023, 1 001. For
C
23H38FNO2Sn (498.3) calculated: 55.47% C, 7.69% H, 2.81% N; foun d: 55.53% C, 7.59% H,
2.99% N.
(E)-4-Acetam ido-3-(tributylstan n yl)but-2-en -1-ol (2v)
an d (E)-4-Acetam ido-2-(tributylstan n yl)but-2-en -1-ol (23)
Th ese stan n an es were prepared as described for com poun ds 2s an d 2l. Two m m ol scale reac-
tion afforded 23 (0.282 g, 34%) as a less polar fraction an d 2v (0.219 g, 26%) as a m ore po-
lar fraction after ch rom atograph y on alum in a (50 g) usin g gradien t elution with petroleum
eth er–eth er–aceton e 55 : 40 : 5, 50 : 40 : 10 an d 40 : 40 : 20.
Compound 23. 1H NMR (CDCl3): 5.61 bs, 1 H (NH); 5.501 tt, 1 H, J1 = 6.9, J2 = 1.9,
3J(Sn -H,cis) = 64 (=CH); 4.38 d, 2 H, J = 5.0, 3J(Sn -H) = 38 (CH2OH); 3.89 t, 2 H, J = 6.0
(CH2NH); 2.29 t,
1 H, J = 5.2 (OH); 1.98 s, 3 H (CH3CO); 1.24–1.60 m , 12 H
(Sn CH2CH2CH2CH3); 0.80–1.02 m , 15 H (Sn CH2CH2CH2CH3). 13C NMR, APT (CDCl3):
170.76, 150.66, 63.84, 38.89, 29.84, 28.08, 10.71 (CH2, C); 135.04, 24.01, 14.42 (CH3, CH).
IR (CHCl3): 3 450, 3 335, 3 008, 2 959, 2 927, 2 872, 2 854, 1 662, 1 519, 1 463, 1 376, 1 273,
1 021. For C18H37NO2Sn (418.2) calculated: 51.70% C, 8.92% H, 3.35% N; foun d: 51.52% C,
8.43% H, 3.20% N.
Collect. Czech. Chem. Commun. (Vol. 65) (2000)